MAA
PTX

Managed Account Advisors’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Managed Account Advisors’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-264
Closed -$28K – 3184
2015
Q1 		$28K Buy
+264
New +$25.2K ﹤0.01% 2693

Other funds holding PTX

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Managed Account Advisors's PTX Position: Q2 2015 in Review

Managed Account Advisors sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2015, closing a stake of 264 shares — an estimated $28K sold.

Managed Account Advisors first reported a position in PTX in Q1 2015 and held it in 1 quarter. The position peaked at $28K in Q1 2015. 114 funds tracked by Wall St. Rank hold PTX as of Q2 2015.

  • Managed Account Advisors reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2015 after selling out during the quarter.
  • Managed Account Advisors sold 264 Pernix Therapeutics Holdings, Inc. shares in Q2 2015, an estimated $28K.
  • Managed Account Advisors first reported a position in Pernix Therapeutics Holdings, Inc. in Q1 2015 and held it in 1 quarter.
  • Managed Account Advisors's Pernix Therapeutics Holdings, Inc. position peaked at $28K in Q1 2015.
  • 114 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.